48
Views
0
CrossRef citations to date
0
Altmetric
Corrigendum

Daclatasvir: potential role in hepatitis C [Corrigendum]

Page 325 | Published online: 20 Mar 2014
This article refers to:
Daclatasvir: potential role in hepatitis C

Lee C. Drug Des Devel Ther. 2013;7:1223–1233.

On page 1231 in the “Conclusion” section, line 3 contains incorrect information. The correct sentence is “This review summarizes key preclinical and clinical data of an HCV NS5A inhibitor, DCV, describing its discovery, mechanism of action, resistance profile, in vitro and in vivo efficacy and toxicity, and polymorphism.”